| Income Statement |
| Total Revenue | 38.25M |
|
| Revenues (USD) | 38.25M |
| Cost of Revenue | 8.92M |
| Gross Profit | 29.33M |
| Operating Expenses | 30.78M |
| Research and Development Expense | 7.02M |
| Selling, General and Administrative Expense | 20.92M |
| Operating Income | -1.44M |
| Interest Expense | -285.00K |
| Income Tax Expense | -5.82M |
| Net Income | 4.67M |
| Net Income Common Stock | 4.67M |
| Net Income Common Stock (USD) | 4.67M |
| Consolidated Income | 4.67M |
| Earnings per Basic Share | 0.03 |
| Earnings per Basic Share (USD) | 0.03 |
| Earnings per Diluted Share | 0.03 |
| Earning Before Interest & Taxes (EBIT) | -1.44M |
| Earning Before Interest & Taxes (USD) | -1.44M |
| Weighted Average Shares | 146.82M |
| Weighted Average Shares Diluted | 152.50M |
| Balance Sheet |
| Cash and Equivalents | 34.56M |
| Cash and Equivalents (USD) | 34.56M |
| Investments | 423.00K |
| Investments Non-Current | 423.00K |
| Trade and Non-Trade Receivables | 44.37M |
| Current Assets | 83.40M |
| Property, Plant & Equipment Net | 31.90M |
| Total Assets | 240.41M |
| Debt Current | 1.39M |
| Total Debt | 11.22M |
| Current Liabilities | 23.72M |
| Debt Non-Current | 9.84M |
| Total Liabilities | 40.89M |
| Accumulated Retained Earnings (Deficit) | -194.91M |
| Shareholders Equity | 199.52M |
| Shareholders Equity (USD) | 199.52M |
| Assets Non-Current | 157.00M |
| Total Debt (USD) | 11.22M |
| Goodwill and Intangible Assets | 123.78M |
| Liabilities Non-Current | 17.17M |
| Trade and Non-Trade Payables | 3.79M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 2.84M |
| Net Cash Flow from Financing | 232.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.98M |
| Capital Expenditure | -2.21M |
| Issuance (Purchase) of Equity Shares | 232.00K |
| Net Cash Flow from Investing | -2.21M |
| Net Cash Flow from Operations | 6.03M |
| Effect of Exchange Rate Changes on Cash | -70.00K |
| Share Based Compensation | 5.50M |